E228-3062 Screening compound: 4-{7-bromo-4-oxo-4H,5H-pyrrolo[1,2-a]quinoxalin-5-yl}-N-[2-(morpholin-4-yl)ethyl]butanamide

E228-3062 Screening compound: 4-{7-bromo-4-oxo-4H,5H-pyrrolo[1,2-a]quinoxalin-5-yl}-N-[2-(morpholin-4-yl)ethyl]butanamide
E228-3062 Screening compound: 4-{7-bromo-4-oxo-4H,5H-pyrrolo[1,2-a]quinoxalin-5-yl}-N-[2-(morpholin-4-yl)ethyl]butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E228-3062
4-{7-bromo-4-oxo-4H,5H-pyrrolo[1,2-a]quinoxalin-5-yl}-N-[2-(morpholin-4-yl)ethyl]butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E228-3062

Molecular Formula

C21H25BrN4O3 (C21 H25 BrN4 O3)

Compound Name

4-{7-bromo-4-oxo-4H,5H-pyrrolo[1,2-a]quinoxalin-5-yl}-N-[2-(morpholin-4-yl)ethyl]butanamide

IUPAC name

4-{7-bromo-4-oxo-4H5H-pyrrolo[12-a]quinoxalin-5-yl}-N-[2-(morpholin-4-yl)ethyl]butanamide

SMILES

O=C(CCCN(c(cc(cc1)Br)c1-n1c2ccc1)C2=O)NCCN1CCOCC1

InChI

InChI=1S/C21H25BrN4O3/c22-16-5-6-17-19(15-16)26(21(28)18-3-1-8-25(17)18)9-2-4-20(27)23-7-10-24-11-13-29-14-12-24/h1,3,5-6,8,15H,2,4,7,9-14H2,(H,23,27)

InChI Key

PKBOSNKIKFIIIN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27598747

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.36

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.614

Distribution Coefficient, logD

1.538

Water Solubility, LogSw

-2.16

Polar Surface Area

53.148

Acid Dissociation Constant (pKa)

13.80

Base Dissociation Constant (pKb)

6.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.90

E228-3062 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E228-3062 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E228-3062?
Check Price and Availability of E228-3062, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E228-3062 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E228-3062
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E228-3062
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E228-3062 available by request